ISPE

NOVEMBER 10, 2022

Later in my career, I started to realize and apply myself to the many gaps that exist between the initial R&D of treatments and how to scale them in manufacturing to bring these products to patients. I focus my work to improve the required methods, equipment, and systems for our emerging industry to scale to meet our vision.

Documentation 98

Documentation Compounding Hospitals Immunization 98

ISPE

OCTOBER 28, 2022

The conference focused on the ongoing development and growth in these technologies, and featured speakers on a broad range of topics, including advanced manufacturing and how lessons learned from COVID-19 vaccine development can apply to biologics development. The Road to Advanced Manufacturing.

Vaccines 52

Vaccines FDA Immunization 52

ISPE

JULY 7, 2023

USP/BIOPHORUM Workshop on Continuous Manufacturing of Biologics Trudy Patterson Fri, 07/07/2023 - 08:45 Features July / August 2023 USP/BIOPHORUM Workshop on Continuous Manufacturing of Biologics John F. 1 Some advantages are apparent based on the nature of a continuous processing, including higher efficiency at lower cost.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

Roots Analysis

SEPTEMBER 22, 2023

These devices are equipped with advanced features like programmable dosing, connectivity to mobile apps, and safety mechanisms to ensure accurate and controlled drug delivery. Patients are more likely to comply with their medication schedules when the process is less cumbersome and requires fewer interactions.

Hospitals 40

Hospitals Dosage Chemotherapy Insurance 40

ISPE

AUGUST 30, 2022

The pharmaceutical manufacturing supply chain starts with the raw materials, which are needed to ensure drug availability for patients. In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP).

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

NOVEMBER 30, 2022

Making Maintenance a True Asset in Pharma Manufacturing Through Digitalization. Making Maintenance a True Asset in Pharma Manufacturing Through Digitalization. A key challenge in life sciences is the detrimental effect of unplanned downtime and lost batches due to unanticipated equipment failure. Trudy Patterson. iSpeak Blog.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52